Archive: https://archive.today/x11qa From the post: >>Ibuprofen is one of the most widely used pain relievers, commonly taken for headaches, menstrual pain, and other everyday aches. New research suggests that its effects may extend beyond pain relief and could include potential anti-cancer benefits. As scientists continue to explore how chronic inflammation contributes to cancer, ibuprofen has drawn growing attention. This has prompted fresh discussion about whether a familiar over-the-counter drug might also play a role in reducing cancer risk. Ibuprofen is part of a group of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). Interest in NSAIDs and cancer prevention dates back decades. In 1983, clinical evidence showed that sulindac, an older prescription NSAID similar to ibuprofen, was associated with lower rates of colon cancer in certain patients. Since then, researchers have examined whether other drugs in this class might help prevent or slow the development of different cancers.